2Halonen M,Eskelin P,Myhre AG,et al.AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-eandidiasis-ectodermal dystrophy phenotype[J].J Clin Endoerinol Metab,2002,87(6):2568-2574.
3Kalfa VC,Roberts RL,Stiehm ER.The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency[J].Ann Allergy Asthma Immunol,2003,90(2):259-264.
4Lever WF,Schaumburg-Lever G,eds.Histopathology of the Skin[M].7th edn.Philadelphia:J.B.Lippincott,1989:37.
6Ahonen P,MyllamiemiS,Sipila I,et al.Clinical variation of autoimmune polyendocrinopathy-eandidiasis-ectodermal dystrophy (APECED) in a series of 68 patients[J].Engl J Med,1990,322(26):1829-1836.
7Sams WM Jr,Jorizzo JL,Snyderman R,et al.Chronic mucocutaneous candidiasis.Immunologic studies of three generations of a single family.Am J Medi,1979,67 (6):948-959.
8Lilic D,Gravenor I,Robson N,et al.Deregulated production of protective cytokines in response to candida albicans infection in patients with chronic mucocutaneous candidiasis.Infect Immun,2003,71 (10):5690-5699.
9Husebye ES,Gebre-Medhin G,Tuomi T,et al.Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type Ⅰ.J Clin Endocrinol Metab,1997,82(1):147-150.
10Clemente MG,Obermayer-Straub P,Meloni A,et al.Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.J Clin Endocrinol Metab,1997,82 (5):1353-1361.
